Table 1.
POCT commercial name | Method/Time to result (min) | Detection of new and emerging respiratory viruses: Sensitivity (%)/Specificity(%) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
HBoV | SARS-CoV | SARS-CoV-2 | MERS-CoV | HCoV-HKU1 | HCoV-NL63 | KIPyV, WUPyV | HMPV | RV-C | Emerging IAV | ||
Cepheid Xpert® Xpress Flu/RSVb,c1 | rRT-PCR/20-30 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | H1N1pdm09, H3N2, AIV (H5N2, H5N8) 97.8/100 |
Mesabiotech™ Accula™ Influenza A&B and RSVa2 | RT-PCR/30 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | H1N1pdm09, H3N2 97/94 |
Sekisui Diagnostics Silaris™ Influenza A&B Test3 | PCR/30 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | H1N1pdm09, H3N2 97/94 |
Cepheid Xpert® Flu/RSV XCb,c | rRT-PCR/40-63 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | H1N1pdm09, H3N2, AIV (H5N2, H5N8) • |
(Cepheid Xpert® Xpress SARS-CoV-2, 2020)e | rRT-PCR/ 45 | N/A | N/A | • | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
BioMérieuxBioFire® FilmArray® Respiratory Panel 2 plus4 | Endpoint melt curve analysis/45 | N/A | N/A | N/A | • | 95.8/99.8 | 95.8/100 | N/A | 94.6/99.2 | N/A | H1N1pdm09, H3N2 88.9-100/99.6-100 |
Quidel® Solana® Respiratory Viral Panel Influenza A&B and RSV & HMPVa5 | RT-HDA/45 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | • | N/A |
Strains not specified
• |
DiaSorin Simplexa™ Flu A/B & RSV Direct Kit6 | RT-PCR/60 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | H1N1pdm09, H3N2, >20 AIVs, 2 swine influenza strains 97/97.9 |
Cepheid Xpert® Flub | rRT-PCR/75 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | H1N1pdm09 97.1-100/99.6 |
Luminex Verigene® RP Flex Test7 | RT-PCR/ <120 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | • | N/A | H1, H3 • |
GenMark Dx® ePlex® Respiratory Paneld | PCR/ <120 | N/A | N/A | N/A | N/A | • | • | N/A | N/A | N/A | H1N1pdm09, H3N2 • |
(GenMark Dx ePlex® SARS-CoV-2 Test, 2020) Teste | rRT-PCR/ <120 | N/A | N/A | • | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
(QIAGEN, 2019) Panel v2 | rRT-PCR/120 | 100/99.5 | N/A | N/A | N/A | 100/100 | 91.7/100 | N/A | 100/100 | N/A | H1N1pdm09, H3N2 91.7-100/100 |
Cepheid Xpert Flu. Product Page. Available online at: https://www.cepheid.com/en/cepheid-solutions/clinical-ivd-tests/critical-infectious-diseases/xpert-flu (accessed September 13, 2019).
Mesabiotech™ Accula™ Flu A/FluB Test Package Insert. Manual. Available online at: https://static1.squarespace.com/static/5ca44a0a7eb88c46af449a53/t/5cddacb3f9689300010d93c3/1558031549318/LBL-60010+Accula+Flu+A+Flu+B+Package+Insert+EU.pdf (accessed November 10, 2019).
Sekisui Diagnostics Silaris™ Influenza A&B Test. Manual. 481. Available online at: https://sekisuidiagnostics.com/product-documents/60012-d_v1.5_silaris_ifu.pdf (accessed November 10, 2019).
Biomerieux BIOFIRE® FILMARRAY® Panels. Product Page. Available online at: https://www.biomerieux-diagnostics.com/filmarrayr-respiratory-panel (accessed September 13, 2019).
Quidel® Solana Respiratory Viral Panel. Product Page. Available online at: https://www.quidel.com/molecular-diagnostics/respiratory-viral-panel (accessed November 10, 2019).
DiaSorin Simplexa® Flu A/B and RSV Direct Kit. Product Page. Available online at: https://molecular.diasorin.com/us/kit/simplexa-flu-ab-rsv-direct-kit/ (accessed November 10, 2019).
Luminex Verigene® Respiratory Pathogens Flex Test. Product Page. Available online at: https://www.luminexcorp.com/respiratory-pathogens-flex-test/ (accessed September 13, 2019).
N/A, Virus not included in this assay; • Virus included, but specificity/sensitivity not available; RT-HAD, Reverse transcriptase helicase-dependent amplification; RT-PCR, Reverse transcriptase polymerase chain reaction; rRT-PCR, real-time RT-PCR; HBoV, Human bocavirus; (H)CoV, (Human) coronavirus; KI/WUPyV, KI/WU polyomavirus; HMPV, Human metapneumovirus; RV-C, Human rhinovirus type C; IAV, Influenza A virus; IBV, Influenza B virus; H1N1pdm09, Influenza A H1N1 pandemic 2009; AIV, Avian influenza virus; RSV, Respiratory Syncytial virus.
Please refer to Supplementary Table 1 for detailed reliability parameters.
Two different kits for Influenza (A, B) and RSV;
Performance reviewed in Basile et al. (2018);
Described in Loeffelholz et al. (2019);
Performance tested by Babady et al. (2018);
For use under the Emergency Use Authorization (EUA) only.